Straits Times Index
3,227.10 -35.97 (-1.10%) S&P 500
3,693.23 -64.76 (-1.72%) Dow
29,590.41 -486.29 (-1.62%) Nasdaq
10,867.93 -198.87 (-1.80%) BTC-USD
18,815.01 -105.43 (-0.56%) CMC Crypto 200
434.61 -9.92 (-2.23%)
Amazon.com Inc (AMZ.SG)
| Previous close | 120.02 |
| Open | 119.74 |
| Bid | 117.38 x 100000 |
| Ask | 117.48 x 100000 |
| Day's range | 115.88 - 119.74 |
| 52-week range | 94.64 - 166.15 |
| Volume | |
| Avg. volume | 4,219 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
5 Things That Are Overpriced at Costco
There are certain products that will generally cost you more money at Costco, so you're better off buying them at the grocery store instead. Pasta is a staple item in many people's pantries -- certainly in mine. Pasta is one of those items that supermarkets tend to discount.
- Motley Fool
3 IPO Stocks That You Want to Own
Three Motley Fool contributors have joined this roundtable to scour the market for some exciting initial public offerings (IPOs) in the healthcare field. Alex Carchidi (Amylyx Pharmaceuticals): Amylyx is worth owning because there's a solid chance it'll soon commercialize the first treatment for amyotrophic lateral sclerosis (ALS) that prolongs survival time while also slowing the disease's progression. Its medicine, AMX0035, has been approved for sale in Canada since late July, and regulators at the U.S. Food and Drug Administration will weigh in on the company's application for commercialization on Sept. 29.
- Motley Fool
2 Potentially Explosive Stocks to Buy in September
These two stocks have such solid growth potential that you might want to buy them before September ends.
